958
The US government shows that combination chemotherapy -the use of several chemical treatments at once -is much more e ective at treating leukaemia (and cancer in general) than giving a single drug.
TREATMENT TIMELINE
Important advances in the treatment of leukaemia. The rst targeted cancer therapy contributes to a sharp rise in survivability for CML.

5-YEAR SURVIVABILITY IN THE UNITED STATES
The likelihood of surviving with leukaemia for 5 years has been increasing steadily for more than 30 years as treatments have improved.
CELL TYPE
At every step in the di erentiation process, the range of fates available to a progenitor cell narrows. Leukaemias can occur at any stage in this process. 
985
A bonemarrow transplant is used to cure leukaemia for the rst time.
986
The National Marrow Donor Program, a US bone-marrow transplant registry, is established.
995
Scientists discover the 'graft-versus-leukaemia' e ect: giving leukaemia patients a dose of healthy white blood cells can help their cancer go back into remission.
2008
Scientists sequence the genome of a patient with acute myeloid leukaemia, paving the way for better targeted therapies.
2004
The rst epigenetic drug is approved to prevent cancer in patients with myelodysplastic syndrome, which can lead to leukaemia. In chronic leukaemias, cancerous progenitor cells continue to mature but fail to develop into fully functional blood cells.
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